Endothelial Dysfunction: From Pathophysiology to Novel Therapeutic Approaches
Dear colleagues, This Special Issue, “Endothelial Dysfunction: From Pathophysiology to Novel Therapeutic Approaches”, focuses on the pathophysiology of endothelial dysfunction, new biomarkers for endothelial dysfunction related to cardiovascular disorders or tumors, and novel therapeutic approaches...
Saved in:
Sonstige: | |
---|---|
Year of Publication: | 2022 |
Language: | English |
Physical Description: | 1 electronic resource (368 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993545191704498 |
---|---|
ctrlnum |
(CKB)5680000000037662 (oapen)https://directory.doabooks.org/handle/20.500.12854/81021 (EXLCZ)995680000000037662 |
collection |
bib_alma |
record_format |
marc |
spelling |
Jeon, Byeong Hwa edt Endothelial Dysfunction: From Pathophysiology to Novel Therapeutic Approaches Endothelial Dysfunction Basel MDPI - Multidisciplinary Digital Publishing Institute 2022 1 electronic resource (368 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier Dear colleagues, This Special Issue, “Endothelial Dysfunction: From Pathophysiology to Novel Therapeutic Approaches”, focuses on the pathophysiology of endothelial dysfunction, new biomarkers for endothelial dysfunction related to cardiovascular disorders or tumors, and novel therapeutic approaches for endothelial dysfunctions. Vascular endothelium is an active tissue and plays a crucial role in the maintenance of vascular homeostasis. Chronic exposure to risk factors, such as hypertension, high cholesterolemia, or oxidative stress, induces endothelial dysfunctions and results in a loss of endothelial integrity, smooth muscle cell proliferation, and macrophage recruitment. The pathophysiology of endothelial dysfunction (ED) is complex and multi-factorial factors are involved, such as oxidative stress or chronic inflammation. The primary prevention of cardiovascular risk factors and endothelial dysfunctions, as well as the early detection of or molecular imaging techniques for endothelial dysfunction, helps to prevent the development of cardiovascular disorders. Novel therapeutic approaches or drug delivery systems for endothelial dysfunctions have had promising beneficial effects in preclinical or clinical levels by affecting the progression of atherosclerotic changes, tumor angiogenesis, and host–immune reactions near tumor environments. English Technology: general issues bicssc Biotechnology bicssc endothelial cells oxidative stress inflammageing endothelial dysfunction aldehyde dehydrogenase-2 cardiovascular disease neurovascular disease vascular inflammation APE1/Ref-1 cardiovascular diseases subcellular localization serological biomarkers atherosclerosis aerobic exercise PCSK9 LOX-1 insulin resistance macrophage polarity serum γ-glutamyltransferase essential hypertension cardiovascular risk factors angiogenesis nargenicin A1 compound 9 VEGF VEGFR2 HIF-1α electronegative low-density lipoprotein LDL(-) L5 LDL oxidized LDL oxLDL ADMA arginine arginine paradox BH4 blood pressure COVID-19 dietary supplements endothelium eNOS uncoupling heart failure hypertension L-arginine myocardial infarction NADPH nitric oxide peripheral artery disease ApoE knockout mouse atorvastatin VCAM-1 galectin-3 neutrophil/lymphocyte ratio electronegative LDL LDL(−) lectin-like oxLDL receptor-1 dyslipidemia chronic venous insufficiency prolyl oligopeptidase (POP) inflammation endothelial disfunction lung disease endothelial to mesenchymal transition pulmonary hypertension pulmonary fibrosis metformin diabetes CV risk hyperglycemia glycated lipoproteins glycated LDL glycated HDL endothelial cell dysfunction molecular mechanisms epigenetic factors therapeutic approaches vasoactive factors EndoMT TGF-β epigenetics endothelial cell glycolysis metabolism pathological angiogenesis tumor microenvironment MRI (magnetic resonance imaging) high-fat diets plaque burden low-level laser therapy phototherapy vascular disease healing ischemia vascular calcification chronic kidney disease CKD uremic toxins hyperphosphatemia vascular smooth muscle cells VSMCs macrophages 3-0365-3036-3 3-0365-3037-1 Jeon, Byeong Hwa oth |
language |
English |
format |
eBook |
author2 |
Jeon, Byeong Hwa |
author_facet |
Jeon, Byeong Hwa |
author2_variant |
b h j bh bhj |
author2_role |
Sonstige |
title |
Endothelial Dysfunction: From Pathophysiology to Novel Therapeutic Approaches |
spellingShingle |
Endothelial Dysfunction: From Pathophysiology to Novel Therapeutic Approaches |
title_full |
Endothelial Dysfunction: From Pathophysiology to Novel Therapeutic Approaches |
title_fullStr |
Endothelial Dysfunction: From Pathophysiology to Novel Therapeutic Approaches |
title_full_unstemmed |
Endothelial Dysfunction: From Pathophysiology to Novel Therapeutic Approaches |
title_auth |
Endothelial Dysfunction: From Pathophysiology to Novel Therapeutic Approaches |
title_alt |
Endothelial Dysfunction |
title_new |
Endothelial Dysfunction: From Pathophysiology to Novel Therapeutic Approaches |
title_sort |
endothelial dysfunction: from pathophysiology to novel therapeutic approaches |
publisher |
MDPI - Multidisciplinary Digital Publishing Institute |
publishDate |
2022 |
physical |
1 electronic resource (368 p.) |
isbn |
3-0365-3036-3 3-0365-3037-1 |
illustrated |
Not Illustrated |
work_keys_str_mv |
AT jeonbyeonghwa endothelialdysfunctionfrompathophysiologytonoveltherapeuticapproaches AT jeonbyeonghwa endothelialdysfunction |
status_str |
n |
ids_txt_mv |
(CKB)5680000000037662 (oapen)https://directory.doabooks.org/handle/20.500.12854/81021 (EXLCZ)995680000000037662 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Endothelial Dysfunction: From Pathophysiology to Novel Therapeutic Approaches |
author2_original_writing_str_mv |
noLinkedField |
_version_ |
1787548866833285120 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05698nam-a2201525z--4500</leader><controlfield tag="001">993545191704498</controlfield><controlfield tag="005">20231214133446.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202205s2022 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5680000000037662</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/81021</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995680000000037662</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Jeon, Byeong Hwa</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Endothelial Dysfunction: From Pathophysiology to Novel Therapeutic Approaches</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Endothelial Dysfunction</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (368 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Dear colleagues, This Special Issue, “Endothelial Dysfunction: From Pathophysiology to Novel Therapeutic Approaches”, focuses on the pathophysiology of endothelial dysfunction, new biomarkers for endothelial dysfunction related to cardiovascular disorders or tumors, and novel therapeutic approaches for endothelial dysfunctions. Vascular endothelium is an active tissue and plays a crucial role in the maintenance of vascular homeostasis. Chronic exposure to risk factors, such as hypertension, high cholesterolemia, or oxidative stress, induces endothelial dysfunctions and results in a loss of endothelial integrity, smooth muscle cell proliferation, and macrophage recruitment. The pathophysiology of endothelial dysfunction (ED) is complex and multi-factorial factors are involved, such as oxidative stress or chronic inflammation. The primary prevention of cardiovascular risk factors and endothelial dysfunctions, as well as the early detection of or molecular imaging techniques for endothelial dysfunction, helps to prevent the development of cardiovascular disorders. Novel therapeutic approaches or drug delivery systems for endothelial dysfunctions have had promising beneficial effects in preclinical or clinical levels by affecting the progression of atherosclerotic changes, tumor angiogenesis, and host–immune reactions near tumor environments.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Technology: general issues</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Biotechnology</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">endothelial cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">oxidative stress</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">inflammageing</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">endothelial dysfunction</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">aldehyde dehydrogenase-2</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cardiovascular disease</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">neurovascular disease</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">vascular inflammation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">APE1/Ref-1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cardiovascular diseases</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">subcellular localization</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">serological biomarkers</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">atherosclerosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">aerobic exercise</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PCSK9</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">LOX-1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">insulin resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">macrophage polarity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">serum γ-glutamyltransferase</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">essential hypertension</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cardiovascular risk factors</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">angiogenesis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nargenicin A1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">compound 9</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">VEGF</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">VEGFR2</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">HIF-1α</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">electronegative low-density lipoprotein</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">LDL(-)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">L5 LDL</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">oxidized LDL</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">oxLDL</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ADMA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">arginine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">arginine paradox</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">BH4</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">blood pressure</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">COVID-19</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">dietary supplements</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">endothelium</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">eNOS uncoupling</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">heart failure</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hypertension</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">L-arginine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">myocardial infarction</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">NADPH</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nitric oxide</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">peripheral artery disease</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ApoE knockout mouse</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">atorvastatin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">VCAM-1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">galectin-3</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">neutrophil/lymphocyte ratio</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">electronegative LDL</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">LDL(−)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lectin-like oxLDL receptor-1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">dyslipidemia</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">chronic venous insufficiency</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">prolyl oligopeptidase (POP)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">inflammation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">endothelial disfunction</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lung disease</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">endothelial to mesenchymal transition</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pulmonary hypertension</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pulmonary fibrosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">metformin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">diabetes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">CV risk</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hyperglycemia</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">glycated lipoproteins</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">glycated LDL</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">glycated HDL</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">endothelial cell dysfunction</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">molecular mechanisms</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">epigenetic factors</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">therapeutic approaches</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">vasoactive factors</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">EndoMT</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">TGF-β</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">epigenetics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">endothelial cell</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">glycolysis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">metabolism</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pathological angiogenesis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tumor microenvironment</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">MRI (magnetic resonance imaging)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">high-fat diets</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">plaque burden</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">low-level laser therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">phototherapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">vascular disease</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">healing</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ischemia</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">vascular calcification</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">chronic kidney disease</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">CKD</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">uremic toxins</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hyperphosphatemia</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">vascular smooth muscle cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">VSMCs</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">macrophages</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-3036-3</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-3037-1</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jeon, Byeong Hwa</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:54:39 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-05-14 21:41:54 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337840000004498&Force_direct=true</subfield><subfield code="Z">5337840000004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337840000004498</subfield></datafield></record></collection> |